Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial.
about
Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationA therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationComparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationIndications for platelet transfusion in patients with thrombocytopeniaWhy has demand for platelet components increased? A reviewOptimal transfusion practices after allogeneic hematopoietic cell transplantation: a systematic scoping review of evidence from randomized controlled trials.Platelet transfusion for patients with cancer.Platelet transfusion in hematology, oncology and surgery.Risk of bleeding and use of platelet transfusions in patients with hematologic malignancies: recurrent event analysis.Alternatives to allogeneic platelet transfusion.Rationale and design of platelet transfusions in haematopoietic stem cell transplantation: the PATH pilot studyComparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders.Platelet refractoriness--practical approaches and ongoing dilemmas in patient management.Prophylactic platelet transfusions in patients with blood malignancies: cost analysis of a randomized trial.Linear decline of corrected platelet count increment within 24 hours after platelet transfusion in haematological patients: A prospective observational study.Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders
P2860
Q24186359-59CCB8CA-FCEB-4C9B-838F-AFA955C8FF59Q24186913-65B9F351-7003-42F6-B260-08F742746DFFQ24187751-89C36D9C-4DFB-4F98-A709-FBCEB09B8293Q27023734-9E193797-F7E6-4F0D-A6B8-E80618EA397AQ28249969-57213D73-131C-461E-B2D7-3DD43B427DCFQ30248755-5873E598-4886-42F8-8B26-8C2274FED76EQ33419329-DCC9E6B9-9F1D-4217-9491-700760199D78Q33419351-856C1D62-00C1-44FF-AAB5-0154AA697B83Q33421355-6AF99DC7-247E-4E50-9121-4139CEBD7154Q33435484-8825F205-4904-416A-802B-C2526AB6503AQ33436425-D65AA4D7-60E6-47BB-A857-7601D78D7043Q37265484-9EC4B741-4F6C-4C51-9C3E-9926E5DCBDA6Q38551094-66393E5B-C02A-412A-A1E4-001A1D4A4BCEQ48076529-F12E1B3F-7025-41D7-BC85-2A55AC1F1B55Q48283082-921C07A3-6C78-43F3-9B4C-B1A3A2E525BFQ57689300-63158466-3C5F-4F6E-AAC5-3795E13ED20E
P2860
Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Impact of prophylactic platele ...... nalysis of a randomized trial.
@en
Impact of prophylactic platele ...... nalysis of a randomized trial.
@nl
type
label
Impact of prophylactic platele ...... nalysis of a randomized trial.
@en
Impact of prophylactic platele ...... nalysis of a randomized trial.
@nl
prefLabel
Impact of prophylactic platele ...... nalysis of a randomized trial.
@en
Impact of prophylactic platele ...... nalysis of a randomized trial.
@nl
P2093
P2860
P356
P1433
P1476
Impact of prophylactic platele ...... nalysis of a randomized trial.
@en
P2093
Charlotte A Llewelyn
Michael F Murphy
Simon J Stanworth
TOPPS Study Investigators
P2860
P304
P356
10.1111/TRF.12646
P577
2014-04-14T00:00:00Z